Zobrazeno 1 - 10
of 152
pro vyhledávání: '"F. Patrick Ross"'
Publikováno v:
Journal of Bone and Mineral Research. 37:2277-2287
Osteoporosis affects over 200 million women worldwide, one-third of whom are predicted to suffer from an osteoporotic fracture in their lifetime. The most promising anabolic drugs involve administration of expensive antibodies. Because mechanical loa
Autor:
null Amanda M. Rooney, null Tyler J. McNeill, null F. Patrick Ross, null Mathias P.G. Bostrom, null Marjolein C.H. van der Meulen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b58135d959a9a5f8ef145757f79e657
https://doi.org/10.1002/jbmr.4728/v3/response1
https://doi.org/10.1002/jbmr.4728/v3/response1
Autor:
Amanda M. Rooney, Tyler J. McNeill, F. Patrick Ross, Mathias P.G. Bostrom, Marjolein C.H. van der Meulen
Publikováno v:
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral ResearchReferences. 38(1)
Parathyroid hormone (PTH) is an anabolic osteoporosis treatment that increases bone mass and reduces fracture risk. Clinically, the effects of PTH are site-specific, increasing bone mass more at the spine than the hip and not increasing bone mass at
Autor:
Amanda M. Rooney, Olufunmilayo O. Ayobami, Natalie H. Kelly, John C. Schimenti, F. Patrick Ross, Marjolein C.H. van der Meulen
Publikováno v:
Bone. 158:116349
Estrogen receptor-alpha (ERα) regulates bone mass and is implicated in bone tissue's response to mechanical loading. The effects of ERα deletion in mice depend on sex, anatomical location, and the cellular stage at which ERα is removed. Few studie
Autor:
Matthew R Steensma, Wakenda K Tyler, Allison G Shaber, Steven R Goldring, F Patrick Ross, Bart O Williams, John H Healey, P Edward Purdue
Publikováno v:
PLoS ONE, Vol 8, Iss 7, p e69101 (2013)
Giant cell tumor of bone (GCTB) is a benign, locally destructive neoplasm, with tumors comprised of mesenchymal fibroblast-like stromal cells; monocytic, mononuclear cells of myeloid lineage; and the characteristic osteoclast-like, multinucleated gia
Externí odkaz:
https://doaj.org/article/bf12d118782d4928a3f58e77023c917f
Publikováno v:
HSS J
BACKGROUND: Peri-prosthetic bone loss can result from chemical, biological, and mechanical factors. Mechanical stimulation via fluid pressure and flow at the bone–implant interface may be a significant cause. Evidence supporting mechanically induce
Publikováno v:
Current Reviews in Musculoskeletal Medicine. 11:380-388
Periprosthetic joint infection (PJI) is a devastating complication after total joint replacement. A main source for antibiotic tolerance and treatment failure is bacterial production of biofilm—a resilient barrier against antibiotics, immune system
Autor:
Marjolein C. H. van der Meulen, Derek T. Holyoak, Olufunmilayo O. Ayobami, F. Patrick Ross, Natalie H. Kelly, Sophia N. Ziemian, Amanda M. Rooney
Publikováno v:
Bone
Objective Reduced subchondral bone mass and increased remodeling are associated with early stage OA. However, the direct effect of low subchondral bone mass on the risk and severity of OA development is unclear. We sought to determine the role of low
Autor:
F. Patrick Ross, Yingzhen Niu, Ilana L. Brito, Gang Ji, Theresa T. Lu, Rowan Callahan, Xu Yang, Susan Chyou, Christopher J. Hernandez, Thomas M. Li, Alberto V. Carli, Arvinth S. Sethuraman, Mathias P.G. Bostrom, Marysol Luna, Matthew B Shirley, Joseph Koressel, Michael W Fields
Publikováno v:
Clin Orthop Relat Res
Periprosthetic joint infection (PJI) is one of the most devastating complications of total joint arthroplasty. Given the mortality and morbidity associated with PJI and the challenges in treating it, there has been increased interest in risk factors